[A combined chemo-endocrine therapy of advanced renal cell carcinoma].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000032:analysis / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006801:Humans; D007680:Kidney Neoplasms / Q000032:analysis / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011960:Receptors, Estrogen / Q000032:analysis; D013629:Tamoxifen / Q000008:administration & dosage*; D005641:Tegafur / Q000008:administration & dosage
D011960:Receptors, Estrogen; D013629:Tamoxifen; D005641:Tegafur; D004317:Doxorubicin; D008727:Methotrexate